Clinical Trials
6 trialsNCT05240040 2026-03-23
Treat Primary and Metastatic Liver Tumors
Methodist Health System
Withdrawn
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT05292443 2024-02-23
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
Withdrawn
NCT03563352 2020-12-14
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
University of Southern California
Withdrawn
NCT00604266 2017-05-04
PET/MRCP
University of Toronto
Withdrawn
NCT01439685 2015-06-03
PDT
Weill Medical College of Cornell University
Withdrawn